Primary study · included by 1 review
Analgesic effect of topical oral capsaicin gel in burning mouth syndrome.
Jørgensen 2017 · Jørgensen Mette Rose, Pedersen Anne Marie Lynge · Acta odontologica Scandinavica · 2017
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Orofacial pain intensity (VAS 0 to 10) Capsaicin (topical or systemic) vs Vehicle (placebo) or lower-dose capsaicin · End of treatment (final assessment) | MD -1.10 [-2.79, 0.58] | 4 studies · 131 participants | Very low |
Orofacial pain intensity (VAS 0 to 10) Capsaicin 0.025% topical oral gel vs Capsaicin 0.01% topical oral gel (lower dose) · End of treatment (final assessment) | MD 0.46 [-2.67, 3.60] | 1 study · 38 participants | GRADE not reported |
Baseline orofacial pain intensity (VAS 0 to 10; group comparability check) Capsaicin (topical or systemic) vs Vehicle (placebo) or lower-dose capsaicin · Baseline (before treatment) | MD 0.48 [-0.59, 1.54] | 4 studies · 131 participants | GRADE not reported |
Baseline orofacial pain intensity (VAS 0 to 10; group comparability check) Capsaicin 0.025% topical oral gel vs Capsaicin 0.01% topical oral gel (lower dose) · Baseline (before treatment) | MD 1.59 [-0.07, 3.25] | 1 study · 38 participants | GRADE not reported |
1 including review in total.